ChemLifeIntel
Access
ChemLifeIntel/Companies/Regenerative Processing Plant, LLC

Regenerative Processing Plant, LLC

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
1
Intelligence Briefs
0
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 1 of 1 briefs on Regenerative Processing Plant, LLC
REGULATORY INTELLIGENCE·Warning Letter

FDA Class II Recall: Regenerative Processing Plant's REGENER-EYES Ophthalmic Solution Lacks Sterility Assurance

Regenerative Processing Plant, LLC has completed a Class II recall of 170,812 bottles of LITE Regener-Eyes Ophthalmic Solution due to a critical lack of sterility assurance. This event, initiated December 10, 2024, impacts nationwide U.S. distribution, necessitating immediate supply chain review for procurement directors. The termination on June 27, 2025, confirms the closure of this specific recall, yet highlights ongoing risks in ophthalmic product manufacturing.

90-Day Activity
Regenerative Processing Plant, LLCREGENER-EYESHSN 2905.45
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2024-12-25